News | October 08, 2009

Philips to Apply Digital Silicon Photomultipliers to Medical Imaging

October 8, 2009 - Royal Philips Electronics said it has developed a digital silicon photomultiplier technology that will allow faster and more accurate photon (the basic quantum unit of light) counting in a wide range of applications where ultra-low light levels need to be measured.

Areas where the new technology could have a major impact include medical imaging, in particular positron emission tomography (PET), and in-vitro diagnostic tests such as DNA sequencing and protein/DNA microarrays. Other relevant areas include high-energy physics, night-vision systems and other applications that currently use light detectors that are based on so-called photomultiplier tubes.

As with virtually all ‘solid-state’ alternatives, this new digital silicon photomultiplier technology should enable the production of smaller and lighter battery-powered equipment for use in areas such as medical diagnostics and surveillance. The key to the technology lies in its ability to combine high-quality single-photon detectors (silicon avalanche photodiodes) with low-voltage CMOS logic on the same silicon substrate. Moreover, these new silicon photomultipliers can be manufactured using a conventional CMOS process technology.

The performance of Philips’ prototype detector, in terms of its speed and dark count level (background noise), will be presented at the IEEE Nuclear Science Symposium and Medical Imaging Conference, which will take place on October 25-31 in Orlando, Fla. Other important features of this new light detection technology include its robustness, low power consumption, light detection efficiency, and very high level of integration of the optical detection and associated electronic components.

“Solid-state digital technology has already taken over from outdated analog solutions in every-day applications such as TVs, camcorders and photography,” says Rob Ballizany, vice president of Philips Corporate Technologies and responsible for the commercialization of this new technology. “...high-end professional applications such as medical imaging will undergo a similar switch to digital detectors in the next few years.”

For more information: www.medical.philips.com

Related Content

Novel PET Tracer Clearly Identifies and Tracks Bacterial Lung Infection

Representative PET/CT images of 18F-FDS and 18F-FDG in inflamed mice. Mice were inoculated with dead K. pneumoniae (10^8 CFU/mL). Imaging was performed for days 1, 2, 3 and 4 using 18F-FDG and 18F-FDS. CT images showed clear inflammation on day 2 and day 3 with corresponding high 18F-FDG uptake on PET. No significant uptake of 18F-FDS was detected for any of those 4 days. Credit: J Li et al., University of Louisville School of Medicine, Louisville, Ky.

News | PET-CT | January 22, 2018
January 22, 2018 — Researchers at the University of Louisville, Kentucky, have demonstrated that a new...
SNMMI Publishes New FDG PET/CT Appropriate Use Criteria
News | PET-CT | October 25, 2017
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for FDG PET/...
Majority of Recurrent Prostate Cancer Patients' Treatment Plan Changed Following Fluciclovine 18F PET/CT
News | Prostate Cancer | October 04, 2017
Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational...
Toshiba Highlights Latest CT Advancements at RSNA 2017
News | Computed Tomography (CT) | September 18, 2017
Toshiba Medical announced that it will display several new enhancements to its existing computed tomography (CT)...
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Blue Earth Diagnostics Announcing Results of FALCON PET/CT Trial at ASTRO 2017
News | PET-CT | September 13, 2017
September 13, 2017 — Blue Earth Diagnostics announced the upcoming oral presentation of initial results from the FALC
FDG-PET/CT Predicts Melanoma Patients' Response to Immune Checkpoint Inhibitor Therapy
News | PET-CT | September 07, 2017
September 7, 2017 — Advanced melanoma has a poor prognosis, but immune checkpoint inhibitor therapy can be effective
Videos | Nuclear Imaging | August 24, 2017
Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and p
ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis
News | Cardiac Imaging | August 18, 2017
August 18, 2017 — The American Society of Nuclear Cardiology (ASNC) has released a joint expert consensus document wi
Overlay Init